Skip to content

Tolerance to Residual Astigmatism in Eyes With Vivity®

Tolerance to Residual Astigmatism and Defocus in Eyes With a Non-diffractive Extended Depth of Focus (EDoF) Intraocular Lens

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05392998
Enrollment
30
Registered
2022-05-26
Start date
2021-06-16
Completion date
2022-03-09
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lenses, Intraocular

Keywords

extended depth of focus intraocular lens, astigmatism

Brief summary

Low amounts of postoperative residual astigmatism may worsen the visual performance of patients implanted with presbyopia- correcting intraocular lenses (IOLs). Although extended depth of focus (EDoF) IOLS have introduced optical improvements, it is important to determine the tolerance of these IOLs to postoperative astigmatism. This is important for an appropriate surgical planning. Therefore, the aim of this study is to simulate and assess the impact of mild amounts of residual mixed astigmatisms with the axis oriented in different positions (vertical, oblique and horizontal) in eyes implanted with the Vivity® IOL.

Detailed description

Objectives: * Primary objective: To describe the tolerance of simulated astigmatism on patients implanted with Vivity at far distance. * Secondary objective: To describe the tolerance of simulated astigmatism on patients implanted with Vivity at intermediate distance. Study Design: Prospective, single arm, descriptive, 3-month follow up. Patient population: 30 consecutive eyes of 30 patients implanted with Vivity bilaterally with no postoperative complications. The calculation of the required sample size was based on monocular corrected distande visual acuity. A difference of 0.2 logMAR units was assumed to be clinically significant anda standard deviation of 0.05 was anticipated(data obtained from a comparative study between a bifocal and a trifocal IOL: Jonker SM, et al. Journal of Cataract Refract Surg. 2015; 41: 1631-40). Based on these assumptions, with an α of 0.05 and power of 0.8, it was calculated that 25 eyes were required in each group. Due to potential dropouts, a larger sample size has been selected. Clinical Protocol: All patients fullfilling study criteria will be considered for inclusion three months after surgery. After patient consent, uncorrected distance visual acuity will be measured with an ETDRS chart, followed by subjective refraction (best distance correction). In all cases, mixed astigmatism will be induced with trial lens over the best distance corrected situation (considered the reference situation). Once the best distance correction is determined, the different visual acuity evaluation procedures for this study will be performed with a Freiburg Acuity Test software package. The software will be run on a separate laptop screen calibrated to be presented at 4 meters. In this procedure, a black Landolt C is presented to the subjects and, among 8 different possibilities, they indicate the orientation of the optotype on a numeric keypad. This test minimizes the observer's bias because the presented optotype depends on the patient´s previous responses. That is, when the observer responds to a certain optotype, the software automatically modifies the size of the next optotype according to parameter estimation by a sequential test method. (7,8) Finally, all serious adverse events will be reported. Statistical Analysis: Visual acuity values will be expressed as mean and standard deviation. Normal distribution of variables will be assessed using the Kolmogorov- Smirnov test. Pre- and post-operative data of each parameter will be compared by means of the Student's t-test. A repeated measure analysis of variance (ANOVA) will be used to gauge any statistically significant difference of the data within the different simulated situations. Differences are considered to be statistically significant for P value \<0.05 (i.e., at the 5% level).

Interventions

DEVICECataract surgery with Vivity intraocular lens implantation

Cataract surgery with Vivity intraocular lens implantation

Sponsors

Alcon Research
CollaboratorINDUSTRY
Clínica Rementería
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients \>40 years old that undergo routine cataract surgery * Bilateral implantation of Vivity ® IOL

Exclusion criteria

* Corneal astigmatism ≥1.0 diopters (D ) * Amblyopia * Previous ocular surgery * Presence of ocular pathologies * Abnormal iris * Patients with intra- or postoperative complications * Postoperative best distance corrected visual acuity (BDCVA) \< 20/20 * Postoperative refractive astigmatism \> 0.50D

Design outcomes

Primary

MeasureTime frameDescription
Distance Against the Rule AstimatismThree months after surgeryChange from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x0\*, taking as a reference the subjects' axis
Distance Oblique AstigmatismThree months after surgeryChange from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x45\*, taking as a reference the subjects' axis
Distance With the Rule AstigmatismThree months after surgeryChange from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x90\*, taking as a reference the subjects' axis

Countries

Spain

Participant flow

Participants by arm

ArmCount
Vivity Patients
The study included patients \>40 years old that underwent routine cataract surgery and IOL implantation. Exclusion criteria included corneal astigmatism ≥1.0 diopters (D), amblyopia, previous ocular surgery, and presence of ocular pathologies and abnormal iris. Patients with intra- or postoperative complications, with a postoperative distance corrected visual acuity (DCVA) \<20/20 and with postoperative refractive astigmatism \>0.50 D were also excluded.
30
Total30

Baseline characteristics

CharacteristicVivity Patients
Age, Continuous69.37 years
STANDARD_DEVIATION 7.1
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
19 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Distance Against the Rule Astimatism

Change from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x0\*, taking as a reference the subjects' axis

Time frame: Three months after surgery

ArmMeasureValue (MEAN)Dispersion
Vivity PatientsDistance Against the Rule Astimatism0.01 LogMARStandard Deviation 0.04
Primary

Distance Oblique Astigmatism

Change from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x45\*, taking as a reference the subjects' axis

Time frame: Three months after surgery

ArmMeasureValue (MEAN)Dispersion
Vivity PatientsDistance Oblique Astigmatism0.01 LogMARStandard Deviation 0.06
Primary

Distance With the Rule Astigmatism

Change from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x90\*, taking as a reference the subjects' axis

Time frame: Three months after surgery

ArmMeasureValue (MEAN)Dispersion
Vivity PatientsDistance With the Rule Astigmatism0.01 LogMARStandard Deviation 0.05

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026